Eligibility Prostate Cancer NCT00020995

Criteria
Description

Criteria

diagnosis of adenocarcinoma of the prostate
Description

adenocarcinoma of the prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
previously untreated and on watchful waiting
Description

watchful waiting

Type de données

boolean

Alias
UMLS CUI [1]
C1298659
medically able to receive dietary intervention
Description

dietary intervention

Type de données

boolean

Alias
UMLS CUI [1]
C0086153
age: 40-80
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
performance status:
Description

performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy:
Description

life expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
hematopoietic:
Description

hematopoietic

Type de données

boolean

Alias
UMLS CUI [1]
C0229601
hepatic:
Description

hepatic

Type de données

boolean

Alias
UMLS CUI [1]
C0205054
renal:
Description

renal

Type de données

boolean

Alias
UMLS CUI [1]
C0232804
other: must be willing to travel to ucla 3 days a week for 4 weeks to obtain specially prepared foods
Description

compliance

Type de données

boolean

Alias
UMLS CUI [1]
C1321605
prior concurrent therapy:
Description

prior concurrent therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0205420
UMLS CUI [1,2]
C1514463
biologic therapy:
Description

biologic therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0005527
chemotherapy:
Description

chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
endocrine therapy:
Description

endocrine therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0279025
no concurrent luteinizing hormone-releasing hormone agonists (leuprolide or goserelin)
Description

concurrent therapy luteinizing hormone-releasing hormone agonists

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C1518041
no concurrent androgen-receptor blocking agents (flutamide or bicalutamide)
Description

concurrent androgen-receptor blocking agents

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C2936804
no concurrent testosterone
Description

concurrent testosterone

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0039601
no concurrent insulin
Description

concurrent insulin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0021641
no concurrent finasteride
Description

concurrent finasteride

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0060389
radiotherapy:
Description

radiotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C1522449
surgery:
Description

surgery

Type de données

boolean

Alias
UMLS CUI [1]
C0543467
no prior orchiectomy
Description

orchiectomy

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0029189
no concurrent saw palmetto supplement
Description

saw palmetto supplement

Type de données

boolean

Alias
UMLS CUI [1]
C2698898

Similar models

Eligibility Prostate Cancer NCT00020995

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
adenocarcinoma of the prostate
Item
diagnosis of adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
watchful waiting
Item
previously untreated and on watchful waiting
boolean
C1298659 (UMLS CUI [1])
dietary intervention
Item
medically able to receive dietary intervention
boolean
C0086153 (UMLS CUI [1])
age
Item
age: 40-80
boolean
C0001779 (UMLS CUI [1])
performance status
Item
performance status:
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy:
boolean
C0023671 (UMLS CUI [1])
hematopoietic
Item
hematopoietic:
boolean
C0229601 (UMLS CUI [1])
hepatic
Item
hepatic:
boolean
C0205054 (UMLS CUI [1])
renal
Item
renal:
boolean
C0232804 (UMLS CUI [1])
compliance
Item
other: must be willing to travel to ucla 3 days a week for 4 weeks to obtain specially prepared foods
boolean
C1321605 (UMLS CUI [1])
prior concurrent therapy
Item
prior concurrent therapy:
boolean
C0205420 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
biologic therapy
Item
biologic therapy:
boolean
C0005527 (UMLS CUI [1])
chemotherapy
Item
chemotherapy:
boolean
C0392920 (UMLS CUI [1])
endocrine therapy
Item
endocrine therapy:
boolean
C0279025 (UMLS CUI [1])
concurrent therapy luteinizing hormone-releasing hormone agonists
Item
no concurrent luteinizing hormone-releasing hormone agonists (leuprolide or goserelin)
boolean
C0009429 (UMLS CUI [1,1])
C1518041 (UMLS CUI [1,2])
concurrent androgen-receptor blocking agents
Item
no concurrent androgen-receptor blocking agents (flutamide or bicalutamide)
boolean
C0009429 (UMLS CUI [1,1])
C2936804 (UMLS CUI [1,2])
concurrent testosterone
Item
no concurrent testosterone
boolean
C0009429 (UMLS CUI [1,1])
C0039601 (UMLS CUI [1,2])
concurrent insulin
Item
no concurrent insulin
boolean
C0009429 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
concurrent finasteride
Item
no concurrent finasteride
boolean
C0009429 (UMLS CUI [1,1])
C0060389 (UMLS CUI [1,2])
radiotherapy
Item
radiotherapy:
boolean
C1522449 (UMLS CUI [1])
surgery
Item
surgery:
boolean
C0543467 (UMLS CUI [1])
orchiectomy
Item
no prior orchiectomy
boolean
C1514463 (UMLS CUI [1,1])
C0029189 (UMLS CUI [1,2])
saw palmetto supplement
Item
no concurrent saw palmetto supplement
boolean
C2698898 (UMLS CUI [1])